Recombinant Human Anti-OPN x Human Anti-VEGF Bispecific Antibody (Fv-IgG) (BSDG-H347)

Recombinant Anti-OPN x Anti-VEGF Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-OPN IgG with similar domains from an anti-VEGF antibody via short peptide linkers, or vice versa. This BsAb can bind two factors simultaneously. It is designed for the research of Hepatocellular cancer; Metastatic cancer therapy.

Datasheet INQUIRY

Specifications

Targets

OPN & VEGF

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Hepatocellular cancer; Metastatic cancer

Targets

Target 1

OPN

Gene ID

6696

UniProt ID

A0A024RDE6

Alternative Names

OPN; BNSP; BSPI; ETA-1; Osteopontin; bone sialoprotein I; BSP-1; SPP1; secreted phosphoprotein 1

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-OPN x Human Anti-VEGF Bispecific Antibody (Fv-IgG) (BSDG-H347). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-OPN x Human Anti-VEGF Bispecific Antibody (Fv-IgG) (CAT#: BSDG-H347)

Specifications

Targets

Customer Reviews and Q&As